127 related articles for article (PubMed ID: 27273257)
21. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
Choi JH; Choi KC; Auersperg N; Leung PC
Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
[TBL] [Abstract][Full Text] [Related]
22. Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.
Wen W; Wu J; Liu L; Tian Y; Buettner R; Hsieh MY; Horne D; Dellinger TH; Han ES; Jove R; Yim JH
Mol Cancer; 2015 May; 14():100. PubMed ID: 25928246
[TBL] [Abstract][Full Text] [Related]
23. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell.
Ptak A; Gregoraszczuk EL
Toxicol Lett; 2012 May; 210(3):332-7. PubMed ID: 22343039
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
26. Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation.
Wayne CM; Fan HY; Cheng X; Richards JS
Mol Endocrinol; 2007 Aug; 21(8):1940-57. PubMed ID: 17536007
[TBL] [Abstract][Full Text] [Related]
27. Delphinidin suppresses proliferation and migration of human ovarian clear cell carcinoma cells through blocking AKT and ERK1/2 MAPK signaling pathways.
Lim W; Jeong W; Song G
Mol Cell Endocrinol; 2016 Feb; 422():172-181. PubMed ID: 26704080
[TBL] [Abstract][Full Text] [Related]
28. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
Cheng JC; Chang HM; Xiong S; So WK; Leung PC
Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
[TBL] [Abstract][Full Text] [Related]
29. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
30. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
31. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
[TBL] [Abstract][Full Text] [Related]
32. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
34. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
35. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells.
Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC
Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning, characterization and expression of thyroid-stimulating hormone receptor in channel catfish.
Goto-Kazeto R; Kazeto Y; Trant JM
Gen Comp Endocrinol; 2009 May; 161(3):313-9. PubMed ID: 19523396
[TBL] [Abstract][Full Text] [Related]
37. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
Kim KY; Choi KC; Auersperg N; Leung PC
Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289
[TBL] [Abstract][Full Text] [Related]
39. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
40. CORRIGENDUM FOR "Thyrostimulin Regulates Osteoblastic Bone Formation During Early Skeletal Development".
Endocrinology; 2018 Apr; 159(4):1762. PubMed ID: 29529189
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
